Wisdom Consulting Advises Revlis Biotech on a US$15mn Private Placement

June 28, 2013
Contact
Vanessa Liu
+886 2 2 2501 5533
press@wisdomwin.com.tw

Wisdom Consulting, a leading boutique consulting firm to start up and established information technology and health sciences companies, announced today it has advised Revlis Biotech on a US$15 million private placement. The proceeds will be used to fund Revlis Biotech's capital investment needs.

Revlis Biotech provides distance health care services by using proprietary cloud computing technology and big data analysis. The company cooperates with top hospitals and medical research institutes throughout Taiwan to deliver efficient treatment solutions that comply with best medical practices. Its next stage of development will include the offering of its treatment solutions to hospitals and patients in markets such as China, Hong Kong, Singapore and the United States.

The Wisdom team was led by chief executive officer David Lai, and included vice president Eric Shen, and associates Yuanta Financial Group. The transaction was notable for being the first time a private operated biotechnology firm in Taiwan raised this level of financing.

“It’s an honor to work once again with Revlis Biotech, a company with which we maintain a close relationship,” said David Lai. "We are proud to have helped our client achieve its goals and to close such a complex transaction in such a short period”.

*** About Wisdom Consulting ***

Wisdom Consulting is a Taipei, Taiwan based consulting firm that specializes in Finance Placement, Business Advisory and Business Development services. The firm is staffed by a team of experienced financial industry professionals and is recognized among its peers for its commitment to transaction execution.